Top

Current Treatment Options in Oncology

Published in:

01-10-2003

Nephrectomy in metastatic renal cell carcinoma

Authors: Steven C. Campbell, MD, PhD, Robert C. Flanigan, MD, Joseph I. Clark, MD

Published in: Current Treatment Options in Oncology | Issue 5/2003

Title: Nephrectomy in metastatic renal cell carcinoma
Authors: Steven C. Campbell, MD, PhD
Robert C. Flanigan, MD
Joseph I. Clark, MD
Publication date: 01-10-2003
Publisher: Current Medicine Group
Published in: Current Treatment Options in Oncology / Issue 5/2003
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI: https://doi.org/10.1007/s11864-003-0037-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/2003

Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer

Metastatic renal cell carcinoma

Laparoscopic approaches to urologic malignancies

Gastrointestinal lymphoma

Gastric cancer: Advances in adjuvant and adjunct therapy

New targeted therapies in gastrointestinal cancers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer